Dna sequencing by parallel oligonucleotide extensions
CA 2218017 C · Owner: Lynx Therapeutics, Inc. · Inventors: Macevicz, Stephen C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Method and compositions are provided for analyzing nucleic acid sequences based on repeated cycles of duplex extension along a single-stranded template. Preferably, such extension starts from a duplex formed between an initializing oligonucleotide and the template. As illustrated in the figure the , initializing oligonucleotide is extended in an initial extension cycle by ligating an oligonucleotide probe to its end to form an extended duplex. The extended duplex is then repeatedly extended by subsequent cycles of ligation. During each cycle, the identity of one or more nucleotides in the template is determined by a label on, or associated with a successfully ligated , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 16, 1996 and granted December 2, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 16, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 16, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.